{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:54:32Z","timestamp":1787025272620,"version":"build-2736575974"},"reference-count":50,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2463\/mrms.rev.2025-0213","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:08:48Z","timestamp":1772057328000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Current Status and Future Perspective for Bladder Cancer MR Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in Japan: Challenges and Solutions"],"prefix":"10.2463","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-8487","authenticated-orcid":false,"given":"Mitsuru","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Radiolonet Tokai, Nagoya, Aichi, Japan"},{"name":"Department of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-9570","authenticated-orcid":false,"given":"Tsutomu","family":"Tamada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kawasaki Medical School, Kurashiki, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71:209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsumoto H, Shiraishi K, Azuma H, et al. Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision. Int J Urol 2020; 27:702\u2013709.","DOI":"10.1111\/iju.14281"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Holzbeierlein JM, Bixler BR, Buckley DI, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline: 2024 amendment. J Urol 2024; 211:533\u2013538.","DOI":"10.1097\/JU.0000000000003846"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2023 guidelines. Eur Urol 2024; 85:17\u201331.","DOI":"10.1016\/j.eururo.2023.08.016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sievert KD, Amend B, Nagele U, et al. Economic aspects of bladder cancer: What are the benefits and costs? World J Urol 2009; 27:295\u2013300.","DOI":"10.1007\/s00345-009-0395-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Breda A, Gallioli A, Diana P, et al. The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: Subgroup analysis of a randomized controlled trial. World J Urol 2023; 41:2583\u20132589.","DOI":"10.1007\/s00345-022-04052-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Balbay MD, Cimentepe E, Unsal A, Bayrak O, Ko\u00e7 A, Akbulut Z. The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 2005; 174:2260\u20132263.","DOI":"10.1097\/01.ju.0000181811.61199.35"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Jindal T, Sarwal A, Jain P, Koju R, Mukherjee S. A retrospective analysis of the factors associated with increased risk of readmission within 30 days after primary transurethral resection of bladder tumor. Curr Urol 2023; 17:257\u2013261.","DOI":"10.1097\/CU9.0000000000000160"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pereira JF, Pareek G, Mueller-Leonhard C, et al. The perioperative morbidity of transurethral resection of bladder tumor: Implications for quality improvement. Urology 2019; 125:131\u2013137.","DOI":"10.1016\/j.urology.2018.10.027"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy. Eur Urol 2007; 51:137\u2013151.","DOI":"10.1016\/j.eururo.2006.05.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Huang J, Fu J, Zhan H, et al. Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue. Urol Int 2012; 89:319\u2013325.","DOI":"10.1159\/000341103"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2018; 73:925\u2013933.","DOI":"10.1016\/j.eururo.2018.02.014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gontero P, Birtle A, Capoun O, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-A summary of the 2024 guidelines update. Eur Urol 2024; 86:531\u2013549.","DOI":"10.1016\/j.eururo.2024.07.027"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018; 74:294\u2013306.","DOI":"10.1016\/j.eururo.2018.04.029"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Panebianco V, Briganti A, Boellaard TN, et al. Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System. Nat Rev Urol 2024; 21:243\u2013251.","DOI":"10.1038\/s41585-023-00830-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Husband JE, Olliff JF, Williams MP, Heron CW, Cherryman GR. Bladder cancer: Staging with CT and MR imaging. Radiology 1989; 173:435\u2013440.","DOI":"10.1148\/radiology.173.2.2798874"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: Diffusion-weighted MR imaging\u2014accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251:112\u2013121.","DOI":"10.1148\/radiol.2511080873"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: A comparison with ultrasonography. BJU Int 2000; 85:32\u201336.","DOI":"10.1046\/j.1464-410x.2000.00358.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Del Giudice F, Flammia RS, Pecoraro M, et al. The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): An updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations. World J Urol 2022; 40:1617\u20131628.","DOI":"10.1007\/s00345-022-03969-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ueno Y, Tamada T, Takeuchi M, et al. VI-RADS: Multiinstitutional multireader diagnostic accuracy and interobserver agreement study. AJR Am J Roentgenol 2021; 216:1257\u20131266.","DOI":"10.2214\/AJR.20.23604"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Del Giudice F, Pecoraro M, Vargas HA, et al. Systematic review and meta-analysis of Vesical Imaging-Reporting and Data System (VI-RADS) inter-observer reliability: An added value for muscle invasive bladder cancer detection. Cancers (Basel) 2020; 12:2994.","DOI":"10.3390\/cancers12102994"},{"key":"22","unstructured":"22. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Bladder Cancer Version 2.2025 \u2014 October 10, 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf (Accessed November 26, 2025)."},{"key":"23","unstructured":"23. Japan Radiological Society. Diagnostic Imaging Guidelines 2021. https:\/\/www.radiology.jp\/content\/files\/gl2021\/diagnostic_imaging_guidelines_2021e.pdf (Accessed November 26, 2025)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dehghanpour A, Davenport MS, Muglia VF, et al. Vesical Imaging Reporting and Data System: Overcoming barriers to global implementation-AJR expert panel narrative review. AJR Am J Roentgenol 2025; AJR.25.33634.","DOI":"10.2214\/AJR.25.33634"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakajima Y, Yamada K, Imamura K, Kobayashi K. Radiologist supply and workload: International comparison. Radiat Med 2008; 26:455\u2013465.","DOI":"10.1007\/s11604-008-0259-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kumamaru KK, Machitori A, Koba R, Ijichi S, Nakajima Y, Aoki S. Global and Japanese regional variations in radiologist potential workload for computed tomography and magnetic resonance imaging examinations. Jpn J Radiol 2018; 36:273\u2013281.","DOI":"10.1007\/s11604-018-0724-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Woo S, Luk L, Muglia VF, et al. VI-RADS quality score: Development and proposal of a scoring system by the American College of Radiology VI-RADS Steering Committee. Eur Radiol 2025. [Online ahead of print]","DOI":"10.1007\/s00330-025-11966-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takeuchi M, Tamada T, Higaki A, Kojima Y, Ueno Y, Yamamoto A. Pictorial review of the diagnosis of muscle-invasive bladder cancer using vesical imaging-reporting and data system (VI-RADS). Abdom Radiol (NY) 2024; 49:4463\u20134480.","DOI":"10.1007\/s00261-024-04424-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kufukihara R, Kikuchi E, Shigeta K, et al. Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy. Urol Oncol 2022; 40:61.e1-61.e8.","DOI":"10.1016\/j.urolonc.2021.07.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Zhan X, Guo J, Chen L, et al. Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients. Cancer Med 2021; 10:6868\u20136880.","DOI":"10.1002\/cam4.4219"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Han YE, Sung DJ, Cho HY, et al. Multiparametric MRI features of plasmacytoid urothelial carcinoma of the urinary bladder. Korean J Radiol 2025; 26:832\u2013840.","DOI":"10.3348\/kjr.2025.0419"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zhang X, Wang Y, Xu X, et al. Bladder MRI with deep learning-based reconstruction: A prospective evaluation of muscle invasiveness using VI-RADS. Abdom Radiol (NY) 2024; 49:1615\u20131625.","DOI":"10.1007\/s00261-024-04280-1"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takeuchi M, Higaki A, Kojima Y, et al. Comparative analysis of image quality and diagnostic performance among SS-EPI, MS-EPI, and rFOV DWI in bladder cancer. Jpn J Radiol 2025; 43:666\u2013675.","DOI":"10.1007\/s11604-024-01694-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ueno Y, Sofue K, Tamada T, et al. Comparison of golden-angle radial sparse parallel (GRASP) and conventional cartesian sampling in 3D dynamic contrast-enhanced mri for bladder cancer: A preliminary study. Jpn J Radiol 2024; 42:1469\u20131478.","DOI":"10.1007\/s11604-024-01637-w"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Takeuchi M, Higaki A, Kojima Y, et al. Diagnostic significance of peritumoral enhancement in distinguishing between muscle-invasive and non-muscle-invasive bladder cancer. Abdom Radiol (NY) 2025; 50:1679\u20131688.","DOI":"10.1007\/s00261-024-04658-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Cai L, Yu R, Liu P, et al. A nomogram of MRI features to assess muscle invasion in VI-RADS 2 tumors with stalk. J Magn Reson Imaging 2024; 59:1179\u20131190.","DOI":"10.1002\/jmri.28924"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Akcay A, Yagci AB, Celen S, Ozlulerden Y, Turk NS, Ufuk F. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer. Clin Imaging 2021; 77:25\u201336.","DOI":"10.1016\/j.clinimag.2021.02.026"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ahn H, Kim TM, Hwang SI, et al. Tumor contact length with bladder wall provides effective risk stratification for lesions with a VIRADS score of 2-3. Eur Radiol 2023; 33:8417\u20138425.","DOI":"10.1007\/s00330-023-09925-1"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Qin C, Tian Q, Zhou H, et al. Detecting muscle invasion of bladder cancer: An application of diffusion kurtosis imaging ratio and Vesical Imaging-Reporting and Data System. J Magn Reson Imaging 2024; 60:54\u201364.","DOI":"10.1002\/jmri.29053"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. \u015eam \u00d6zdemir M, Azamat S, \u00d6zdemir H, et al. Preoperative prediction of muscle invasiveness in bladder cancer: The role of 3D volumetric radiomics using diffusion-weighted MRI, the VI-RADS score, or a combination of both. Ann Surg Oncol 2024; 31:5845\u20135850.","DOI":"10.1245\/s10434-024-15760-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gong Y, Zhang X, Xia YF, et al. A foundation model with weak experiential guidance in detecting muscle invasive bladder cancer on MRI. Cancer Lett 2025; 611:217438.","DOI":"10.1016\/j.canlet.2025.217438"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Cai L, Yang X, Yu J, et al. Deep learning on T2WI to predict the muscle-invasive bladder cancer: A multi-center clinical study. Sci Rep 2025; 15:9942.","DOI":"10.1038\/s41598-024-82909-3"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Li J, Qiu Z, Cao K, et al. Predicting muscle invasion in bladder cancer based on MRI: A comparison of radiomics, and single-task and multi-task deep learning. Comput Methods Programs Biomed 2023; 233:107466.","DOI":"10.1016\/j.cmpb.2023.107466"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Zou Y, Cai L, Chen C, et al. Multi-task deep learning based on T2-weighted images for predicting muscular-invasive bladder cancer. Comput Biol Med 2022; 151(Pt A):106219.","DOI":"10.1016\/j.compbiomed.2022.106219"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kurata Y, Nishio M, Moribata Y, et al. Development of deep learning model for diagnosing muscle-invasive bladder cancer on MRI with vision transformer. Heliyon 2024; 10:e36144.","DOI":"10.1016\/j.heliyon.2024.e36144"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Bicchetti M, Simone G, Giannarini G, et al. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: Results of a prospective multicenter study. Radiol Med 2022; 127:881\u2013890.","DOI":"10.1007\/s11547-022-01513-5"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Del Giudice F, Barchetti G, De Berardinis E, et al. Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur Urol 2020; 77:101\u2013109.","DOI":"10.1016\/j.eururo.2019.09.029"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Bryan RT, Liu W, Pirrie SJ, et al. Randomized comparison of magnetic resonance imaging versus transurethral resection for staging new bladder cancers: Results from the prospective BladderPath trial. J Clin Oncol 2025; 43:1417\u20131428.","DOI":"10.1200\/JCO-25-00779"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. van Koeverden SW, van Hoogstraten LM, de Rooij M, et al. Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: Study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study). BMJ Open 2025; 15:e100002.","DOI":"10.1136\/bmjopen-2025-100002"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Del Giudice F, Vestri A, Fegatelli DA, et al. VI-RADS followed by photodynamic transurethral resection of non-muscle-invasive bladder cancer vs white-light conventional and second-resection: the \u2018CUT-less\u2019 randomised trial protocol. BJU Int 2025; 135:346\u2013354.","DOI":"10.1111\/bju.16531"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/3\/25_rev.2025-0213\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:04:02Z","timestamp":1783141442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/3\/25_rev.2025-0213\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.rev.2025-0213","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"rev.2025-0213"}}